Robert Freedman
Concepts (528)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 69 | 2020 | 501 | 9.540 |
Why?
| Choline | 10 | 2021 | 109 | 3.810 |
Why?
| Nicotinic Agonists | 14 | 2016 | 110 | 3.620 |
Why?
| Receptors, Nicotinic | 34 | 2013 | 295 | 3.610 |
Why?
| Evoked Potentials, Auditory | 35 | 2020 | 201 | 2.990 |
Why?
| Brain | 33 | 2021 | 2490 | 2.830 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 22 | 2016 | 105 | 2.540 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2021 | 468 | 2.260 |
Why?
| Hippocampus | 27 | 2013 | 735 | 2.180 |
Why?
| Hot Flashes | 7 | 2014 | 72 | 2.170 |
Why?
| Psychotic Disorders | 8 | 2021 | 135 | 2.130 |
Why?
| Sensory Gating | 8 | 2020 | 42 | 2.030 |
Why?
| Psychiatry | 5 | 2018 | 201 | 1.930 |
Why?
| Schizophrenic Psychology | 19 | 2015 | 113 | 1.920 |
Why?
| Periodicals as Topic | 5 | 2018 | 191 | 1.900 |
Why?
| Neural Inhibition | 16 | 2013 | 160 | 1.840 |
Why?
| Pregnancy Complications, Infectious | 4 | 2021 | 296 | 1.750 |
Why?
| Benzylidene Compounds | 7 | 2013 | 25 | 1.740 |
Why?
| Nicotine | 17 | 2013 | 276 | 1.680 |
Why?
| Fetal Development | 8 | 2021 | 250 | 1.500 |
Why?
| Antidepressive Agents | 3 | 2023 | 189 | 1.430 |
Why?
| Chromosomes, Human, Pair 15 | 16 | 2015 | 64 | 1.370 |
Why?
| Ketamine | 2 | 2023 | 93 | 1.360 |
Why?
| Attention | 17 | 2020 | 408 | 1.350 |
Why?
| Pyridines | 7 | 2013 | 440 | 1.340 |
Why?
| Maternal Exposure | 2 | 2019 | 142 | 1.230 |
Why?
| Menopause | 4 | 2014 | 266 | 1.070 |
Why?
| Pursuit, Smooth | 8 | 2007 | 23 | 1.050 |
Why?
| Evoked Potentials | 7 | 2020 | 115 | 1.000 |
Why?
| Gestational Age | 4 | 2021 | 765 | 0.990 |
Why?
| Pregnancy | 16 | 2021 | 5694 | 0.970 |
Why?
| Child Behavior | 2 | 2016 | 212 | 0.940 |
Why?
| Mental Disorders | 4 | 2021 | 939 | 0.940 |
Why?
| Dietary Supplements | 5 | 2021 | 467 | 0.930 |
Why?
| Electroconvulsive Therapy | 1 | 2023 | 8 | 0.920 |
Why?
| Folic Acid | 3 | 2021 | 161 | 0.920 |
Why?
| Acoustic Stimulation | 17 | 2020 | 321 | 0.910 |
Why?
| Body Temperature Regulation | 4 | 2013 | 73 | 0.880 |
Why?
| Prenatal Care | 4 | 2021 | 252 | 0.880 |
Why?
| Humans | 117 | 2023 | 119032 | 0.870 |
Why?
| Reflex, Startle | 3 | 2014 | 63 | 0.840 |
Why?
| Phosphatidylcholines | 3 | 2018 | 133 | 0.820 |
Why?
| Infant Behavior | 2 | 2020 | 22 | 0.790 |
Why?
| Micronutrients | 2 | 2021 | 79 | 0.780 |
Why?
| Child Development | 4 | 2021 | 410 | 0.780 |
Why?
| Neurons | 10 | 2019 | 1345 | 0.740 |
Why?
| Female | 68 | 2021 | 61588 | 0.740 |
Why?
| Smoking | 14 | 2013 | 1487 | 0.730 |
Why?
| Auditory Perception | 7 | 2004 | 106 | 0.710 |
Why?
| Prefrontal Cortex | 3 | 2016 | 275 | 0.700 |
Why?
| Hallucinogens | 1 | 2021 | 74 | 0.700 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2018 | 56 | 0.700 |
Why?
| Editorial Policies | 2 | 2018 | 46 | 0.670 |
Why?
| Saccades | 7 | 2007 | 51 | 0.660 |
Why?
| Perceptual Disorders | 3 | 2005 | 21 | 0.660 |
Why?
| Endophenotypes | 2 | 2015 | 28 | 0.660 |
Why?
| Hydrocortisone | 1 | 2020 | 273 | 0.660 |
Why?
| Adult | 49 | 2021 | 31525 | 0.650 |
Why?
| Nootropic Agents | 2 | 2020 | 27 | 0.640 |
Why?
| Electroencephalography | 9 | 2020 | 387 | 0.620 |
Why?
| Premature Birth | 1 | 2021 | 284 | 0.620 |
Why?
| Depression | 2 | 2023 | 1137 | 0.610 |
Why?
| Antipsychotic Agents | 7 | 2008 | 193 | 0.610 |
Why?
| Infant, Newborn | 8 | 2021 | 5256 | 0.590 |
Why?
| Male | 71 | 2021 | 57818 | 0.590 |
Why?
| Problem Behavior | 1 | 2018 | 85 | 0.590 |
Why?
| Betacoronavirus | 1 | 2020 | 254 | 0.590 |
Why?
| Primary Prevention | 1 | 2018 | 185 | 0.560 |
Why?
| Arousal | 6 | 1993 | 157 | 0.550 |
Why?
| Marijuana Smoking | 1 | 2019 | 220 | 0.550 |
Why?
| Psychological Trauma | 1 | 2016 | 55 | 0.540 |
Why?
| Magnetic Resonance Imaging | 11 | 2013 | 3175 | 0.530 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.530 |
Why?
| Afferent Pathways | 3 | 2013 | 44 | 0.530 |
Why?
| Cognition Disorders | 3 | 2010 | 529 | 0.510 |
Why?
| Brain Mapping | 4 | 2013 | 532 | 0.500 |
Why?
| Amygdala | 1 | 2016 | 175 | 0.500 |
Why?
| Aggression | 1 | 2016 | 184 | 0.490 |
Why?
| Cannabis | 1 | 2021 | 382 | 0.490 |
Why?
| Reaction Time | 7 | 2020 | 392 | 0.490 |
Why?
| Genotype | 9 | 2015 | 1882 | 0.480 |
Why?
| Teaching | 1 | 2016 | 236 | 0.470 |
Why?
| C-Reactive Protein | 3 | 2020 | 364 | 0.460 |
Why?
| Sleep Apnea Syndromes | 1 | 2014 | 80 | 0.460 |
Why?
| Phosphorylcholine | 1 | 2013 | 18 | 0.450 |
Why?
| Bungarotoxins | 9 | 2008 | 44 | 0.450 |
Why?
| Mothers | 5 | 2021 | 683 | 0.440 |
Why?
| Double-Blind Method | 6 | 2016 | 1687 | 0.440 |
Why?
| Genetic Linkage | 10 | 2012 | 321 | 0.420 |
Why?
| Neuropsychological Tests | 6 | 2016 | 1032 | 0.420 |
Why?
| Sleep | 3 | 2014 | 660 | 0.420 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 324 | 0.420 |
Why?
| Ocular Motility Disorders | 2 | 2004 | 27 | 0.410 |
Why?
| Emotions | 2 | 2016 | 495 | 0.400 |
Why?
| Gyrus Cinguli | 3 | 2006 | 68 | 0.400 |
Why?
| Neural Pathways | 3 | 2010 | 277 | 0.400 |
Why?
| Middle Aged | 28 | 2016 | 27627 | 0.390 |
Why?
| Cognition | 3 | 2016 | 1025 | 0.380 |
Why?
| Interneurons | 5 | 2001 | 103 | 0.380 |
Why?
| 5-Hydroxytryptophan | 1 | 2009 | 22 | 0.360 |
Why?
| Infant | 9 | 2021 | 8295 | 0.360 |
Why?
| Dopamine | 7 | 2009 | 249 | 0.360 |
Why?
| Schizotypal Personality Disorder | 2 | 2002 | 10 | 0.360 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2009 | 37 | 0.360 |
Why?
| Cerebral Cortex | 5 | 2006 | 416 | 0.360 |
Why?
| Sensation Disorders | 2 | 2007 | 33 | 0.350 |
Why?
| Thalamus | 2 | 2007 | 80 | 0.350 |
Why?
| Peer Review, Research | 1 | 2009 | 35 | 0.350 |
Why?
| Fetus | 4 | 2021 | 690 | 0.350 |
Why?
| Biomedical Research | 1 | 2015 | 612 | 0.350 |
Why?
| Cocaine-Related Disorders | 2 | 2001 | 107 | 0.340 |
Why?
| Body Temperature | 2 | 2007 | 215 | 0.330 |
Why?
| Nitric Oxide Synthase | 2 | 2000 | 225 | 0.330 |
Why?
| Writing | 1 | 2009 | 88 | 0.320 |
Why?
| Substance Withdrawal Syndrome | 2 | 2007 | 157 | 0.320 |
Why?
| Neurons, Afferent | 2 | 1999 | 89 | 0.310 |
Why?
| Sensory Aids | 1 | 2007 | 1 | 0.310 |
Why?
| Miniaturization | 1 | 2007 | 24 | 0.300 |
Why?
| Humidity | 1 | 2007 | 45 | 0.300 |
Why?
| Neostriatum | 1 | 2007 | 30 | 0.300 |
Why?
| Equipment and Supplies | 1 | 2007 | 39 | 0.300 |
Why?
| Learning | 2 | 2009 | 374 | 0.300 |
Why?
| Phenotype | 7 | 2018 | 3004 | 0.290 |
Why?
| Biomarkers | 3 | 2015 | 3590 | 0.290 |
Why?
| Sleep, REM | 2 | 2006 | 53 | 0.290 |
Why?
| Contingent Negative Variation | 2 | 2005 | 7 | 0.290 |
Why?
| Child of Impaired Parents | 2 | 1996 | 42 | 0.280 |
Why?
| Pedigree | 8 | 2009 | 485 | 0.280 |
Why?
| Acetylcholine | 3 | 2002 | 208 | 0.280 |
Why?
| Genetic Markers | 7 | 2012 | 348 | 0.280 |
Why?
| Internship and Residency | 1 | 2016 | 1006 | 0.280 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 10 | 0.280 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2005 | 13 | 0.280 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 10 | 0.280 |
Why?
| Child | 9 | 2021 | 19137 | 0.270 |
Why?
| Sensation | 3 | 1991 | 43 | 0.260 |
Why?
| Nicotinic Antagonists | 4 | 2008 | 19 | 0.260 |
Why?
| Galvanic Skin Response | 3 | 2013 | 28 | 0.260 |
Why?
| Receptors, Cholinergic | 5 | 2009 | 46 | 0.260 |
Why?
| Time Perception | 1 | 2005 | 23 | 0.260 |
Why?
| Animals | 32 | 2021 | 33399 | 0.250 |
Why?
| Cross-Over Studies | 3 | 2016 | 456 | 0.250 |
Why?
| Eye Movements | 3 | 2013 | 56 | 0.250 |
Why?
| Mice, Inbred C3H | 2 | 2001 | 250 | 0.240 |
Why?
| Image Processing, Computer-Assisted | 4 | 2013 | 710 | 0.240 |
Why?
| Child, Preschool | 5 | 2021 | 9493 | 0.240 |
Why?
| Sleep Deprivation | 1 | 2006 | 164 | 0.240 |
Why?
| Bipolar Disorder | 4 | 2007 | 209 | 0.240 |
Why?
| Genetic Predisposition to Disease | 5 | 2013 | 2275 | 0.240 |
Why?
| Pyramidal Cells | 3 | 2003 | 54 | 0.230 |
Why?
| Norepinephrine | 5 | 1992 | 212 | 0.230 |
Why?
| Mice, Inbred DBA | 2 | 2008 | 174 | 0.220 |
Why?
| Homovanillic Acid | 5 | 1990 | 7 | 0.220 |
Why?
| Promoter Regions, Genetic | 4 | 2003 | 1158 | 0.220 |
Why?
| Linkage Disequilibrium | 2 | 2009 | 273 | 0.200 |
Why?
| Publishing | 2 | 2016 | 131 | 0.200 |
Why?
| Hearing Disorders | 1 | 2001 | 10 | 0.200 |
Why?
| Rats | 16 | 2002 | 5394 | 0.200 |
Why?
| Social Problems | 1 | 2021 | 11 | 0.200 |
Why?
| Reward | 1 | 2023 | 209 | 0.200 |
Why?
| Oxygen | 3 | 2013 | 857 | 0.200 |
Why?
| Vitamin A | 1 | 2021 | 55 | 0.200 |
Why?
| Phencyclidine | 3 | 1992 | 4 | 0.200 |
Why?
| Vitamin D | 2 | 2021 | 354 | 0.190 |
Why?
| Fatty Acids, Omega-3 | 2 | 2021 | 125 | 0.190 |
Why?
| Frontal Lobe | 3 | 2006 | 148 | 0.190 |
Why?
| Sweating | 2 | 2013 | 24 | 0.190 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 366 | 0.190 |
Why?
| Clozapine | 3 | 2004 | 21 | 0.180 |
Why?
| Object Attachment | 1 | 2020 | 31 | 0.180 |
Why?
| Vitamins | 1 | 2021 | 159 | 0.180 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2446 | 0.180 |
Why?
| Chromosome Mapping | 4 | 2009 | 510 | 0.180 |
Why?
| Schizophrenia, Childhood | 1 | 1999 | 4 | 0.180 |
Why?
| Young Adult | 4 | 2019 | 10799 | 0.170 |
Why?
| Bombesin | 1 | 1999 | 15 | 0.170 |
Why?
| Alleles | 5 | 2009 | 832 | 0.170 |
Why?
| Psychiatric Status Rating Scales | 4 | 2005 | 499 | 0.170 |
Why?
| Analysis of Variance | 5 | 2008 | 1295 | 0.170 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 159 | 0.170 |
Why?
| Rats, Sprague-Dawley | 8 | 2002 | 2478 | 0.170 |
Why?
| Risk Factors | 10 | 2021 | 9003 | 0.170 |
Why?
| Genetic Variation | 3 | 2003 | 926 | 0.170 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 195 | 0.170 |
Why?
| Maternal Age | 1 | 2019 | 122 | 0.170 |
Why?
| RNA, Messenger | 7 | 2006 | 2661 | 0.170 |
Why?
| Nutritional Status | 1 | 2021 | 300 | 0.170 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 47 | 0.160 |
Why?
| Psychomotor Performance | 4 | 2005 | 291 | 0.160 |
Why?
| Catecholamines | 3 | 2002 | 100 | 0.160 |
Why?
| DNA Mutational Analysis | 3 | 2013 | 381 | 0.160 |
Why?
| Stem Cells | 1 | 2002 | 559 | 0.160 |
Why?
| Reference Values | 6 | 1996 | 775 | 0.160 |
Why?
| History, 21st Century | 1 | 2018 | 170 | 0.160 |
Why?
| Dentate Gyrus | 1 | 1997 | 32 | 0.160 |
Why?
| Irritable Mood | 1 | 2018 | 51 | 0.150 |
Why?
| Family | 4 | 2015 | 587 | 0.150 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 815 | 0.150 |
Why?
| Urinary Tract Infections | 1 | 2019 | 136 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2012 | 2062 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 4 | 2010 | 1947 | 0.150 |
Why?
| Postmortem Changes | 3 | 2006 | 16 | 0.150 |
Why?
| Disease Models, Animal | 7 | 2009 | 3730 | 0.150 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2017 | 29 | 0.150 |
Why?
| Adolescent | 11 | 2017 | 18483 | 0.150 |
Why?
| Neurocognitive Disorders | 1 | 1996 | 25 | 0.140 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 336 | 0.140 |
Why?
| Skin Temperature | 2 | 2006 | 17 | 0.140 |
Why?
| Treatment Outcome | 2 | 2023 | 9346 | 0.140 |
Why?
| Chewing Gum | 2 | 2007 | 8 | 0.140 |
Why?
| Gene Expression | 5 | 2006 | 1492 | 0.140 |
Why?
| Prepulse Inhibition | 1 | 2015 | 10 | 0.140 |
Why?
| Benzodiazepines | 2 | 2008 | 123 | 0.140 |
Why?
| Vanilmandelic Acid | 4 | 1990 | 4 | 0.130 |
Why?
| Methoxyhydroxyphenylglycol | 4 | 1990 | 11 | 0.130 |
Why?
| Cell Differentiation | 1 | 2002 | 1753 | 0.130 |
Why?
| Pandemics | 2 | 2021 | 1355 | 0.130 |
Why?
| Cerebrovascular Circulation | 2 | 2007 | 204 | 0.130 |
Why?
| Nitric Oxide | 1 | 2000 | 893 | 0.130 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 331 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 348 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 339 | 0.130 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2013 | 140 | 0.130 |
Why?
| Postmenopause | 2 | 2007 | 306 | 0.130 |
Why?
| Hot Temperature | 2 | 2007 | 334 | 0.130 |
Why?
| Snoring | 1 | 2014 | 11 | 0.120 |
Why?
| Corpus Striatum | 2 | 1992 | 127 | 0.120 |
Why?
| Twins | 1 | 1996 | 247 | 0.120 |
Why?
| Synapsins | 1 | 1993 | 13 | 0.120 |
Why?
| Synaptophysin | 1 | 1993 | 12 | 0.120 |
Why?
| Clonidine | 1 | 2013 | 22 | 0.120 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 30 | 0.120 |
Why?
| Sleep Stages | 1 | 1993 | 60 | 0.120 |
Why?
| Brain Tissue Transplantation | 1 | 1992 | 19 | 0.110 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.110 |
Why?
| Polymorphism, Genetic | 4 | 2009 | 642 | 0.110 |
Why?
| Zinc | 1 | 1995 | 262 | 0.110 |
Why?
| Perinatal Care | 1 | 2013 | 37 | 0.110 |
Why?
| Mesencephalon | 1 | 1992 | 57 | 0.110 |
Why?
| gamma-Aminobutyric Acid | 3 | 2003 | 155 | 0.110 |
Why?
| Genomics | 1 | 2018 | 705 | 0.110 |
Why?
| United States | 3 | 2018 | 12557 | 0.110 |
Why?
| Estrogen Replacement Therapy | 1 | 2013 | 117 | 0.110 |
Why?
| Pregnancy Complications | 2 | 2019 | 448 | 0.110 |
Why?
| Heart Rate | 2 | 2007 | 729 | 0.110 |
Why?
| Functional Laterality | 1 | 2013 | 208 | 0.110 |
Why?
| Parasympathetic Nervous System | 1 | 1992 | 25 | 0.110 |
Why?
| Inflammation | 2 | 2021 | 2571 | 0.110 |
Why?
| Stress, Psychological | 1 | 2020 | 976 | 0.110 |
Why?
| Auditory Pathways | 1 | 1992 | 54 | 0.110 |
Why?
| Circadian Rhythm | 2 | 2013 | 401 | 0.110 |
Why?
| Iodine Radioisotopes | 4 | 2001 | 130 | 0.110 |
Why?
| Immunity | 1 | 2013 | 129 | 0.110 |
Why?
| Severity of Illness Index | 3 | 2015 | 2674 | 0.100 |
Why?
| Gene Frequency | 2 | 2005 | 513 | 0.100 |
Why?
| Memory | 1 | 2013 | 230 | 0.100 |
Why?
| Gene Duplication | 3 | 2015 | 64 | 0.100 |
Why?
| Blood Pressure | 3 | 2007 | 1664 | 0.100 |
Why?
| Synaptic Transmission | 5 | 1999 | 239 | 0.100 |
Why?
| Sleep Apnea, Obstructive | 1 | 2014 | 234 | 0.090 |
Why?
| Case-Control Studies | 4 | 2012 | 3173 | 0.090 |
Why?
| Aged | 9 | 2015 | 19661 | 0.090 |
Why?
| Genetic Association Studies | 1 | 2012 | 371 | 0.090 |
Why?
| Electrophysiology | 5 | 1996 | 204 | 0.090 |
Why?
| Education, Distance | 1 | 2009 | 36 | 0.090 |
Why?
| Electromyography | 2 | 2005 | 326 | 0.090 |
Why?
| Anxiety Disorders | 1 | 2012 | 309 | 0.090 |
Why?
| Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| Sequence Deletion | 1 | 2009 | 171 | 0.080 |
Why?
| Diazepam | 1 | 1988 | 23 | 0.080 |
Why?
| Field Dependence-Independence | 1 | 2008 | 3 | 0.080 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 80 | 0.080 |
Why?
| Lorazepam | 1 | 1988 | 24 | 0.080 |
Why?
| Parkinson Disease | 1 | 1992 | 334 | 0.080 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2008 | 5 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4552 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 963 | 0.080 |
Why?
| Follow-Up Studies | 2 | 2013 | 4596 | 0.080 |
Why?
| Glycols | 1 | 1988 | 5 | 0.080 |
Why?
| Rats, Inbred Strains | 6 | 1992 | 394 | 0.080 |
Why?
| Evoked Potentials, Somatosensory | 1 | 1988 | 33 | 0.080 |
Why?
| Prospective Studies | 1 | 2019 | 6477 | 0.080 |
Why?
| Auditory Perceptual Disorders | 2 | 2008 | 11 | 0.080 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 1244 | 0.080 |
Why?
| Genes | 2 | 1998 | 231 | 0.080 |
Why?
| Microsatellite Repeats | 2 | 2012 | 143 | 0.080 |
Why?
| Models, Neurological | 2 | 2000 | 216 | 0.070 |
Why?
| Auditory Cortex | 1 | 2007 | 41 | 0.070 |
Why?
| Depressive Disorder | 1 | 1990 | 333 | 0.070 |
Why?
| Diseases in Twins | 1 | 1988 | 181 | 0.070 |
Why?
| Time Factors | 3 | 2005 | 6414 | 0.070 |
Why?
| Monitoring, Ambulatory | 1 | 2007 | 84 | 0.070 |
Why?
| Alcoholism | 2 | 1995 | 717 | 0.070 |
Why?
| Cerebellum | 4 | 1988 | 203 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 736 | 0.070 |
Why?
| Telemetry | 1 | 2005 | 32 | 0.070 |
Why?
| Cold Temperature | 1 | 2006 | 132 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2007 | 1795 | 0.070 |
Why?
| Memory, Short-Term | 1 | 2008 | 233 | 0.070 |
Why?
| Genome | 2 | 2006 | 278 | 0.070 |
Why?
| Menstrual Cycle | 1 | 2006 | 113 | 0.070 |
Why?
| Predictive Value of Tests | 2 | 2007 | 1868 | 0.060 |
Why?
| Sequence Analysis, DNA | 3 | 2003 | 755 | 0.060 |
Why?
| Internet | 1 | 2009 | 633 | 0.060 |
Why?
| Visual Pathways | 1 | 2005 | 43 | 0.060 |
Why?
| Quetiapine Fumarate | 1 | 2004 | 25 | 0.060 |
Why?
| Parietal Lobe | 1 | 2005 | 42 | 0.060 |
Why?
| Dibenzothiazepines | 1 | 2004 | 20 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 27 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 307 | 0.060 |
Why?
| Verbal Behavior | 1 | 2004 | 48 | 0.060 |
Why?
| Mice | 6 | 2009 | 15528 | 0.060 |
Why?
| Area Under Curve | 1 | 2005 | 296 | 0.060 |
Why?
| Dopamine D2 Receptor Antagonists | 1 | 2003 | 5 | 0.060 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 191 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2003 | 22 | 0.060 |
Why?
| Visual Fields | 1 | 2004 | 78 | 0.060 |
Why?
| Early Diagnosis | 1 | 2005 | 230 | 0.060 |
Why?
| Single-Blind Method | 1 | 2004 | 269 | 0.060 |
Why?
| Mental Recall | 2 | 1996 | 180 | 0.060 |
Why?
| Administration, Oral | 1 | 2005 | 756 | 0.060 |
Why?
| Pain Measurement | 1 | 2005 | 469 | 0.060 |
Why?
| Head | 1 | 2004 | 89 | 0.060 |
Why?
| Action Potentials | 6 | 1993 | 420 | 0.060 |
Why?
| Oxygen Consumption | 1 | 2005 | 586 | 0.060 |
Why?
| Age of Onset | 2 | 2007 | 467 | 0.060 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 239 | 0.060 |
Why?
| Purkinje Cells | 5 | 1988 | 65 | 0.050 |
Why?
| Exons | 3 | 2015 | 308 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 551 | 0.050 |
Why?
| Sex Characteristics | 1 | 2007 | 671 | 0.050 |
Why?
| Chromosome Disorders | 2 | 1999 | 39 | 0.050 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2001 | 15 | 0.050 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2001 | 18 | 0.050 |
Why?
| Radioligand Assay | 1 | 2001 | 45 | 0.050 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2001 | 20 | 0.050 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2001 | 43 | 0.050 |
Why?
| Lod Score | 1 | 2001 | 75 | 0.050 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 64 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 63 | 0.050 |
Why?
| Chromosome Aberrations | 2 | 1999 | 136 | 0.050 |
Why?
| Cloning, Molecular | 2 | 2000 | 546 | 0.050 |
Why?
| Movement | 1 | 2004 | 248 | 0.050 |
Why?
| Binding, Competitive | 1 | 2001 | 205 | 0.050 |
Why?
| Hallucinations | 1 | 2001 | 29 | 0.050 |
Why?
| Cell Count | 1 | 2001 | 315 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 75 | 0.050 |
Why?
| Lymphocytes | 1 | 2002 | 347 | 0.050 |
Why?
| Fornix, Brain | 1 | 2000 | 6 | 0.050 |
Why?
| Denervation | 1 | 2000 | 21 | 0.050 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2000 | 48 | 0.050 |
Why?
| Family Health | 1 | 2001 | 201 | 0.050 |
Why?
| Point Mutation | 2 | 1999 | 228 | 0.050 |
Why?
| Multifactorial Inheritance | 1 | 2001 | 143 | 0.050 |
Why?
| Animals, Newborn | 1 | 2002 | 806 | 0.050 |
Why?
| Blotting, Northern | 2 | 2005 | 194 | 0.040 |
Why?
| Algorithms | 1 | 2007 | 1543 | 0.040 |
Why?
| Blotting, Western | 3 | 2005 | 1195 | 0.040 |
Why?
| Binding Sites | 1 | 2002 | 1224 | 0.040 |
Why?
| Genetic Testing | 1 | 2001 | 389 | 0.040 |
Why?
| Fathers | 1 | 1999 | 47 | 0.040 |
Why?
| Cocaine | 1 | 2001 | 158 | 0.040 |
Why?
| Event-Related Potentials, P300 | 1 | 1998 | 13 | 0.040 |
Why?
| Photic Stimulation | 1 | 1999 | 204 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 982 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 3 | 1989 | 490 | 0.040 |
Why?
| Cell Movement | 1 | 2002 | 897 | 0.040 |
Why?
| Self Medication | 1 | 1998 | 8 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 247 | 0.040 |
Why?
| Cholinergic Agents | 1 | 1998 | 18 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1998 | 115 | 0.040 |
Why?
| Heterozygote | 1 | 1998 | 262 | 0.040 |
Why?
| Genetics, Population | 1 | 1999 | 207 | 0.040 |
Why?
| Electric Conductivity | 2 | 1998 | 91 | 0.040 |
Why?
| Parents | 2 | 2015 | 1212 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2001 | 1691 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2000 | 509 | 0.040 |
Why?
| Conditioning, Classical | 2 | 2008 | 89 | 0.040 |
Why?
| Age Factors | 2 | 2006 | 2995 | 0.040 |
Why?
| Memory Disorders | 1 | 1998 | 168 | 0.040 |
Why?
| Electrooculography | 1 | 1996 | 11 | 0.040 |
Why?
| In Situ Hybridization | 2 | 2013 | 311 | 0.040 |
Why?
| Base Sequence | 3 | 2009 | 2160 | 0.040 |
Why?
| Risk | 1 | 1999 | 854 | 0.030 |
Why?
| Sensory Thresholds | 1 | 1996 | 30 | 0.030 |
Why?
| Motor Activity | 2 | 1992 | 666 | 0.030 |
Why?
| Nerve Fibers | 1 | 1995 | 89 | 0.030 |
Why?
| Receptors, Glutamate | 1 | 1995 | 20 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2007 | 4709 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 1995 | 74 | 0.030 |
Why?
| Placenta | 1 | 2021 | 641 | 0.030 |
Why?
| Nerve Net | 1 | 1998 | 232 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 332 | 0.030 |
Why?
| Siblings | 1 | 2015 | 235 | 0.030 |
Why?
| Aging | 2 | 1999 | 1677 | 0.030 |
Why?
| Dyskinesia, Drug-Induced | 1 | 1994 | 11 | 0.030 |
Why?
| Cholinergic Fibers | 1 | 1993 | 19 | 0.030 |
Why?
| Horseradish Peroxidase | 1 | 1993 | 27 | 0.030 |
Why?
| Orientation | 1 | 1994 | 43 | 0.030 |
Why?
| Neuromuscular Junction | 1 | 1994 | 53 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1995 | 1012 | 0.030 |
Why?
| Synaptic Vesicles | 1 | 1993 | 38 | 0.030 |
Why?
| Axonal Transport | 1 | 1993 | 21 | 0.030 |
Why?
| Genetic Engineering | 1 | 1994 | 83 | 0.030 |
Why?
| Chronic Disease | 1 | 1999 | 1637 | 0.030 |
Why?
| Temporal Lobe | 1 | 1993 | 90 | 0.030 |
Why?
| Tissue Banks | 1 | 2013 | 19 | 0.030 |
Why?
| Peptides | 1 | 1999 | 879 | 0.030 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 55 | 0.030 |
Why?
| DNA Probes | 1 | 2013 | 60 | 0.030 |
Why?
| Nomifensine | 1 | 1992 | 3 | 0.030 |
Why?
| Habituation, Psychophysiologic | 1 | 1993 | 56 | 0.030 |
Why?
| HLA-A Antigens | 1 | 2013 | 50 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1597 | 0.030 |
Why?
| Receptors, sigma | 1 | 1992 | 1 | 0.030 |
Why?
| Poly A | 1 | 1993 | 47 | 0.030 |
Why?
| Levodopa | 1 | 1992 | 23 | 0.030 |
Why?
| Genes, MHC Class I | 1 | 2013 | 33 | 0.030 |
Why?
| Biogenic Monoamines | 1 | 1992 | 14 | 0.030 |
Why?
| Tomography, Emission-Computed | 1 | 1992 | 58 | 0.030 |
Why?
| Benzylamines | 1 | 1992 | 40 | 0.030 |
Why?
| Tubocurarine | 1 | 1992 | 3 | 0.030 |
Why?
| N-Methylaspartate | 1 | 1992 | 38 | 0.030 |
Why?
| Mecamylamine | 1 | 1992 | 7 | 0.030 |
Why?
| Parasympatholytics | 1 | 1992 | 14 | 0.030 |
Why?
| Wakefulness | 1 | 1993 | 128 | 0.030 |
Why?
| Sympathomimetics | 1 | 1992 | 26 | 0.030 |
Why?
| Injections, Intraventricular | 1 | 1992 | 73 | 0.030 |
Why?
| Nervous System | 1 | 1992 | 66 | 0.030 |
Why?
| Microelectrodes | 1 | 1992 | 33 | 0.030 |
Why?
| Muscles | 1 | 1994 | 333 | 0.030 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 16 | 0.030 |
Why?
| Temperature | 1 | 1995 | 622 | 0.030 |
Why?
| Genotyping Techniques | 1 | 2012 | 75 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.030 |
Why?
| DNA Replication | 1 | 1993 | 211 | 0.030 |
Why?
| Transcription, Genetic | 1 | 1997 | 1323 | 0.030 |
Why?
| RNA | 2 | 2013 | 833 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1993 | 397 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 348 | 0.020 |
Why?
| Recombinant Proteins | 1 | 1994 | 1308 | 0.020 |
Why?
| Introns | 2 | 2003 | 234 | 0.020 |
Why?
| Risk Assessment | 1 | 1999 | 3057 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 2003 | 2873 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1994 | 495 | 0.020 |
Why?
| Adenylate Cyclase Toxin | 1 | 1989 | 8 | 0.020 |
Why?
| Receptors, Dopamine | 1 | 1989 | 13 | 0.020 |
Why?
| Virulence Factors, Bordetella | 1 | 1989 | 20 | 0.020 |
Why?
| Pertussis Toxin | 1 | 1989 | 29 | 0.020 |
Why?
| Blotting, Southern | 1 | 2009 | 67 | 0.020 |
Why?
| Autoanalysis | 1 | 1989 | 6 | 0.020 |
Why?
| Adenylyl Cyclases | 1 | 1989 | 86 | 0.020 |
Why?
| Electrochemistry | 1 | 1989 | 69 | 0.020 |
Why?
| Yohimbine | 1 | 1988 | 9 | 0.020 |
Why?
| Dioxins | 1 | 1988 | 4 | 0.020 |
Why?
| Dioxanes | 1 | 1988 | 8 | 0.020 |
Why?
| Odds Ratio | 1 | 2012 | 996 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 1989 | 147 | 0.020 |
Why?
| Dihydro-beta-Erythroidine | 1 | 2008 | 3 | 0.020 |
Why?
| Gene Dosage | 1 | 2009 | 136 | 0.020 |
Why?
| Cell Line | 2 | 2009 | 2707 | 0.020 |
Why?
| Receptors, Adrenergic | 1 | 1988 | 36 | 0.020 |
Why?
| Tyramine | 1 | 1988 | 10 | 0.020 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 311 | 0.020 |
Why?
| Pulse | 1 | 1988 | 27 | 0.020 |
Why?
| Saliva | 1 | 1989 | 188 | 0.020 |
Why?
| Fluphenazine | 1 | 1987 | 5 | 0.020 |
Why?
| Tobacco Use Disorder | 1 | 2010 | 233 | 0.020 |
Why?
| Audiometry, Evoked Response | 1 | 1987 | 15 | 0.020 |
Why?
| Stereoisomerism | 1 | 1987 | 93 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 403 | 0.020 |
Why?
| Autoradiography | 2 | 1997 | 72 | 0.020 |
Why?
| Mutation | 2 | 2015 | 3457 | 0.020 |
Why?
| Tyrosine | 1 | 1988 | 233 | 0.020 |
Why?
| Drug Interactions | 1 | 2008 | 352 | 0.020 |
Why?
| Depressive Disorder, Major | 1 | 2010 | 303 | 0.020 |
Why?
| Suicide | 1 | 1993 | 500 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2007 | 164 | 0.020 |
Why?
| ROC Curve | 1 | 2007 | 473 | 0.020 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2006 | 26 | 0.020 |
Why?
| Transcription Factors | 1 | 1994 | 1570 | 0.020 |
Why?
| alpha Catenin | 1 | 2005 | 14 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 124 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 675 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 536 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1987 | 261 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1384 | 0.010 |
Why?
| Logistic Models | 1 | 2007 | 1901 | 0.010 |
Why?
| Fourier Analysis | 1 | 2002 | 41 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1323 | 0.010 |
Why?
| Artifacts | 1 | 2002 | 125 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 1781 | 0.010 |
Why?
| Diet | 1 | 1988 | 1155 | 0.010 |
Why?
| Contig Mapping | 1 | 1998 | 10 | 0.010 |
Why?
| Genes, Duplicate | 1 | 1998 | 3 | 0.010 |
Why?
| Restriction Mapping | 1 | 1998 | 76 | 0.010 |
Why?
| Receptors, Presynaptic | 1 | 1998 | 6 | 0.010 |
Why?
| Macaca radiata | 1 | 1997 | 16 | 0.010 |
Why?
| Models, Biological | 1 | 2005 | 1715 | 0.010 |
Why?
| Autopsy | 1 | 1997 | 90 | 0.010 |
Why?
| Organ Specificity | 1 | 1997 | 278 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1996 | 405 | 0.010 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 35 | 0.010 |
Why?
| Species Specificity | 1 | 1996 | 565 | 0.010 |
Why?
| Gene Amplification | 1 | 1995 | 97 | 0.010 |
Why?
| Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| tau Proteins | 1 | 1995 | 78 | 0.010 |
Why?
| Protein Disulfide-Isomerases | 1 | 1994 | 10 | 0.010 |
Why?
| Genes, Fungal | 1 | 1994 | 49 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 73 | 0.010 |
Why?
| Glycosylation | 1 | 1994 | 129 | 0.010 |
Why?
| DNA Primers | 1 | 1995 | 533 | 0.010 |
Why?
| Molecular Biology | 1 | 1994 | 58 | 0.010 |
Why?
| Cadaver | 1 | 1995 | 327 | 0.010 |
Why?
| Fungal Proteins | 1 | 1994 | 130 | 0.010 |
Why?
| Genetic Vectors | 1 | 1994 | 302 | 0.010 |
Why?
| DNA | 1 | 1998 | 1388 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1994 | 2073 | 0.010 |
Why?
| Idazoxan | 1 | 1988 | 1 | 0.010 |
Why?
| Phentolamine | 1 | 1988 | 17 | 0.010 |
Why?
| Receptors, Adrenergic, alpha | 1 | 1988 | 32 | 0.010 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 245 | 0.010 |
Why?
| Desipramine | 1 | 1988 | 9 | 0.010 |
Why?
| Receptors, Adrenergic, beta | 1 | 1988 | 144 | 0.000 |
Why?
| Magnesium | 1 | 1987 | 150 | 0.000 |
Why?
| DNA-Binding Proteins | 1 | 1994 | 1346 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1995 | 6562 | 0.000 |
Why?
|
|
Freedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|